Triple

T17056553
Position Surface form Disambiguated ID Type / Status
Subject FDA field laboratories E413835 entity
Predicate partOf P40 FINISHED
Object FDA Office of Regulatory Affairs E88389 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA Office of Regulatory Affairs | Statement: [FDA field laboratories, partOf, FDA Office of Regulatory Affairs]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: FDA Office of Regulatory Affairs
Context triple: [FDA field laboratories, partOf, FDA Office of Regulatory Affairs]
  • A. Office of Regulatory Affairs chosen
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • B. U.S. Food and Drug Administration Office of Operations
    The U.S. Food and Drug Administration Office of Operations is the FDA component responsible for overseeing the agency’s administrative, financial, and operational support functions across its programs and facilities.
  • C. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • D. U.S. Food and Drug Administration Office of Regulatory Science
    The U.S. Food and Drug Administration Office of Regulatory Science is an FDA division that conducts scientific research and analysis to support regulatory decisions on the safety, effectiveness, and quality of food, drugs, and other products under the agency’s oversight.
  • E. Office of Generic Drugs
    The Office of Generic Drugs is a division of the U.S. Food and Drug Administration responsible for reviewing and approving generic medications to ensure they are safe, effective, and therapeutically equivalent to brand-name drugs.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886cde3d481908d4d01ba88ba7eb7 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3db7a96288190bd985f79c3f55623 completed April 18, 2026, 7:28 p.m.
NED1 Entity disambiguation (via context triple) batch_6a012346bcfc819093cd922baa94e186 completed May 11, 2026, 12:31 a.m.
Created at: April 10, 2026, 5:34 a.m.